First nine months 2015 results.
SCOR delivers robust results for the first nine months of 2015, combining growth, profitability and solvency, and pursues the active implementation of the “Optimal Dynamics” strategic plan.
More and more individuals use – be it on purpose or unknowingly – devices that track medical and behavioural data, and the cost of such devices is steadily falling, contributing further to their integration into daily
During its annual Investor Day being held today in Paris, SCOR’s Executive Management team, led by Denis Kessler, will present an overview of the successful implementation of the strategic plan “Optimal Dynamics” in i
Chinese version - The trend of cancer incidences is one of the key questions for developing critical illness (CI) and cancer insurance products with a sustainable price.
The trend of cancer incidences is one of the key questions for developing critical illness (CI) and cancer insurance products with a sustainable price.
Half year 2015 results.
SCOR announces the publication of its interim financial report for the six months ended 30 June 2015
Over 35 million people in the world are HIVpositive. Again, as long as treatment and regular medical follow-up show an absence of immunosuppression, some of these people can be offered life cover.